CORE LABORATORIES N V Net Cash Provided by (Used in) Financing Activities in USD from Q1 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Core Laboratories N V quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2010 to Q1 2023.
  • Core Laboratories N V Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $6.06M.
  • Core Laboratories N V annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$23.4M, a 4.08% decline from 2021.
  • Core Laboratories N V annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$22.5M, a 64.4% increase from 2020.
  • Core Laboratories N V annual Net Cash Provided by (Used in) Financing Activities for 2020 was -$63M, a 26.6% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

CORE LABORATORIES N V Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $6.06M +$7.45M Jan 1, 2023 Mar 31, 2023 10-Q 2023-04-27
Q1 2022 -$1.38M -$8.47M -120% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q1 2021 $7.08M +$22.4M Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q1 2020 -$15.3M +$4.52M +22.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-23
Q1 2019 -$19.9M -$229K -1.17% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-24
Q1 2018 -$19.6M +$3.93M +16.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-26
Q1 2017 -$23.6M +$25.4M +51.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q1 2016 -$48.9M +$27.9M +36.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-21
Q1 2015 -$76.8M -$19.8M -34.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-22
Q1 2014 -$57M -$1.99M -3.63% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-29
Q1 2013 -$55M -$3.39M -6.58% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-25
Q1 2012 -$51.6M +$55.7M +51.9% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-19
Q1 2011 -$107M -$18.2M -20.5% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-23
Q1 2010 -$89M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-22

CORE LABORATORIES N V Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$23.4M -$916K -4.08% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-10
2021 -$22.5M +$40.5M +64.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-10
2020 -$63M +$22.9M +26.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-10
2019 -$85.9M -$43.4M -102% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-10
2018 -$42.5M +$61.6M +59.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-08
2017 -$104M +$20.8M +16.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-10
2016 -$125M +$55.4M +30.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-11
2015 -$180M +$82.8M +31.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-12
2014 -$263M -$14M -5.64% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-10
2013 -$249M -$35.8M -16.8% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-12
2012 -$213M +$43.4M +16.9% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-17
2011 -$257M -$42.4M -19.8% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-13
2010 -$214M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.